These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 28900709)

  • 1. Pretransplant Intra-arterial Liver-Directed Therapy Does Not Increase the Risk of Hepatic Arterial Complications in Liver Transplantation: A Single-Center 10-Year Experience.
    Kallini JR; Gabr A; Ali R; Abouchaleh N; Riaz A; Baker T; Kulik L; Caicedo J; Salem R; Lewandowski RJ
    Cardiovasc Intervent Radiol; 2018 Feb; 41(2):231-238. PubMed ID: 28900709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and Efficacy of Transarterial Radioembolization Combined with Chemoembolization for Bilobar Hepatocellular Carcinoma: A Single-Center Retrospective Study.
    Kwon JH; Kim GM; Han K; Won JY; Kim MD; Lee DY; Lee J; Choi W; Kim YS; Kim DY; Han KH
    Cardiovasc Intervent Radiol; 2018 Mar; 41(3):459-465. PubMed ID: 29067511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative transarterial chemoembolization does not increase hepatic artery complications after liver transplantation: A single center 12-year experience.
    Li H; Li B; Wei Y; Yan L; Wen T; Wang W; Yang J; Lu W; Xu M
    Clin Res Hepatol Gastroenterol; 2015 Sep; 39(4):451-7. PubMed ID: 25623860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization.
    Lewandowski RJ; Kulik LM; Riaz A; Senthilnathan S; Mulcahy MF; Ryu RK; Ibrahim SM; Sato KT; Baker T; Miller FH; Omary R; Abecassis M; Salem R
    Am J Transplant; 2009 Aug; 9(8):1920-8. PubMed ID: 19552767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does Preoperative Transarterial Chemoembolization for Hepatocellular Carcinoma Increase the Incidence of Hepatic Artery Thrombosis After Living-Donor Liver Transplant?
    Ince V; Ersan V; Karakas S; Kutluturk K; Karadag N; Kutlu R; Yilmaz S
    Exp Clin Transplant; 2017 Mar; 15(Suppl 2):21-24. PubMed ID: 28301994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transarterial chemoembolization versus transarterial radioembolization in hepatocellular carcinoma: optimization of selecting treatment modality.
    Kim DY; Han KH
    Hepatol Int; 2016 Nov; 10(6):883-892. PubMed ID: 27126821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of post-transplant outcomes in hepatocellular carcinoma patients treated with chemoembolization or radioembolization.
    Gabr A; Abouchaleh N; Ali R; Vouche M; Atassi R; Memon K; Asadi AA; Baker T; Caicedo JC; Desai K; Fryer J; Hickey R; Abeccassis M; Habib A; Hohlastos E; Ganger D; Kulik L; Lewandowski RJ; Riaz A; Salem R
    Eur J Radiol; 2017 Aug; 93():100-106. PubMed ID: 28668402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma.
    Kallini JR; Gabr A; Salem R; Lewandowski RJ
    Adv Ther; 2016 May; 33(5):699-714. PubMed ID: 27039186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transarterial Chemoembolization and (90)Y Radioembolization for Hepatocellular Carcinoma: Review of Current Applications Beyond Intermediate-Stage Disease.
    Fidelman N; Kerlan RK
    AJR Am J Roentgenol; 2015 Oct; 205(4):742-52. PubMed ID: 26397322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unresectable Hepatocellular Carcinoma: Radioembolization Versus Chemoembolization: A Systematic Review and Meta-analysis.
    Lobo L; Yakoub D; Picado O; Ripat C; Pendola F; Sharma R; ElTawil R; Kwon D; Venkat S; Portelance L; Yechieli R
    Cardiovasc Intervent Radiol; 2016 Nov; 39(11):1580-1588. PubMed ID: 27586657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic artery and biliary complications in liver transplant recipients with radioembolization bridging treatment for hepatocellular carcinoma.
    Radunz S; Saner FH; Treckmann J; Rekowski J; Theysohn JM; Müller S; Best J; Sotiropoulos GC; Paul A; Benkö T
    Clin Transplant; 2017 Nov; 31(11):. PubMed ID: 28836737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transarterial chemoembolization of hepatocellular carcinoma before liver transplantation and risk of post-transplant vascular complications: a multicentre observational cohort and propensity score-matched analysis.
    Sneiders D; Boteon APCS; Lerut J; Iesari S; Gilbo N; Blasi F; Larghi Laureiro Z; Orlacchio A; Tisone G; Lai Q; Pirenne J; Polak WG; Perera MTPR; Manzia TM; Hartog H
    Br J Surg; 2021 Nov; 108(11):1323-1331. PubMed ID: 34611694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transarterial chemoembolization and yittrium-90 for liver cancer and other lesions.
    Minocha J; Salem R; Lewandowski RJ
    Clin Liver Dis; 2014 Nov; 18(4):877-90. PubMed ID: 25438288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of Blood Pressure Changes in the Vascular Compartment When Using an Anti-Reflux Catheter during Chemoembolization versus Radioembolization: A Retrospective Case Series.
    Rose SC; Narsinh KH; Newton IG
    J Vasc Interv Radiol; 2017 Jan; 28(1):103-110. PubMed ID: 27840042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic artery and biliary complications in liver transplant recipients undergoing pretransplant transarterial chemoembolization.
    Goel A; Mehta N; Guy J; Fidelman N; Yao F; Roberts J; Terrault N
    Liver Transpl; 2014 Oct; 20(10):1221-8. PubMed ID: 25045002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic arterial complications in liver transplant recipients treated with pretransplantation chemoembolization for hepatocellular carcinoma.
    Richard HM; Silberzweig JE; Mitty HA; Lou WY; Ahn J; Cooper JM
    Radiology; 2000 Mar; 214(3):775-9. PubMed ID: 10715045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic artery complications following liver transplantation. Does preoperative chemoembolization impact the postoperative course?
    Panaro F; Ramos J; Gallix B; Mercier G; Herrero A; Niampa H; Pageaux GP; Navarro F
    Clin Transplant; 2014 May; 28(5):598-605. PubMed ID: 24628275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of the safety and efficacy of transcatheter arterial chemoembolization and yttrium-90 radioembolization in patients with unresectable hepatocellular carcinoma.
    Lance C; McLennan G; Obuchowski N; Cheah G; Levitin A; Sands M; Spain J; Srinivas S; Shrikanthan S; Aucejo FN; Kim R; Menon KV
    J Vasc Interv Radiol; 2011 Dec; 22(12):1697-705. PubMed ID: 21983055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis: adjusted indirect comparison of drug-eluting bead transarterial chemoembolization versus
    Ludwig JM; Zhang D; Xing M; Kim HS
    Eur Radiol; 2017 May; 27(5):2031-2041. PubMed ID: 27562480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioembolization for the treatment of hepatocellular carcinoma.
    Kim HC
    Clin Mol Hepatol; 2017 Jun; 23(2):109-114. PubMed ID: 28494530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.